Sectors

Crescent Enterprises’ corporate venturing arm reinvested in the furniture rental service in a series D round pushing its overall debt and equity financing past $240m.

On-demand logistics provider Pickupp hiked its overall funding to $15m while SK Chemicals added to the $67m already raised by drug discovery technology producer Standigm.

UC Berkeley’s cell therapy developer has filed for an initial public offering.

Ant Group is set to score an exit when the financial technology platform operator lists in Korea next month in an IPO sized at up to $1.5bn.

The BMW, Dell and Robert Bosch-backed manufacturing services platform has added just over $44m to its initial public offering, its shares having risen 58%.

AbbVie, Novartis, Corteva and Heritage Medical Systems will have an opportunity to exit the cell therapy developer through an initial public offering.

The CyberAgent, JD.com, Sumitomo and VNG-backed e-commerce marketplace has reached a first close for its series E round, ahead of a $100m second tranche expected in the next few months.

ClalTech is set to exit the cloud infrastructure management software provider in an acquisition by HPE, which will integrate Zerto with its storage division.

Coinbase Ventures, Razer’s zVentures unit, Samsung Venture Investment and Scopely were among the investors that took part in a $50m tranche to help the mobile game publisher close its latest round.

Sirnaomics, which counts Walvax Bio, China Resources Group and Charoen Pokphand Group as existing investors, has raised series E funding to advance its drug development activities.

Accenture, Chevron, ConocoPhillips, General Electric, Intel, Shell and Saudi Aramco have all exited the operations management software provider in a purchase by SparkCognition.